Second quarter revenue and earnings exceeded expectations, driven by strong growth in Nurse and Allied Solutions and strategic acquisitions. Non-recurring items boosted margins, but guidance for Q3 reflects normalization. Cash position and reduced leverage support further acquisitions and share repurchases.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.